Definitive Contract W81XWH22C0154
Award Date 9/30/22
Potential Completion Date 9/29/25
Potential Value $6.1M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price Level of Effort
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Uniformed Services University of the Health Sciences (USUHS) awarded a definitive contract to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. on September 30, 2025, for the Meningococcal Immunization Against Gonococcal Infection (MAGI) Trial/RV564. This $1.21 million cost-plus-fixed-fee contract supports a clinical research initiative focused on evaluating meningococcal vaccines for their potential effectiveness against gonococcal infection, with performance...
- This is a $417,953.02 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Icon Government and Public Health Solutions, Inc. to execute a clinical trial protocol (NCT02210325). The contract has no set-aside designation. Icon Government and Public Health Solutions, Inc., a global contract research organization, is the prime contractor. It has subcontracted portions of...
- This is a $1,744,771.70 Firm Fixed Price delivery order awarded by the U.S. Army Medical Command (MEDCOM) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), a nonprofit organization. The award is under the Navy Medicine R&D Support Omnibus III indefinite delivery vehicle and supports a malaria clinical research study for the Department of Immunology and Medicine at the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand. The...
- This is a Cost Plus Fixed Fee delivery order awarded by the Bureau of Medicine and Surgery (Navy Medicine) to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. (HJF) under the Navy Medicine R&D Support Omnibus III contract vehicle. The $5,783,938.31 contract is for a study to evaluate the efficacy, immunogenicity, and safety of a norovirus bivalent virus-like particle (VLP) vaccine in adults, with a period of performance ending on October 31, 2018. HJF is a...
- This is a $5,356,859.28 federal contract awarded by the Defense Health Agency to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), a non-profit organization. The contract is for the development of a bovine immunoglobulin (BIgG) supplement to prevent traveler's diarrhea caused by Enterotoxigenic E. coli (ETEC). The contract includes several subcontractors to support the overall effort, including The Emmes Company LLC for data management and clinical...
- This is a $6,209,903.46 cost-plus-fixed-fee definitive contract awarded by the Uniformed Services University of the Health Sciences (USUHS) to the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) on September 30, 2022. The contract is for the development of clinical practice guidelines to support the care of military-relevant infectious diseases, with a period of performance through September 29, 2024. The original solicitation was a Sources Sought Notice...
- This firm-fixed-price purchase order was awarded by the U.S. Army Medical Command (MEDCOM) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) for $149,553.60. The award is for the provision of a Non-Personal Clinical Research Associate to support a follow-on continuing investigative study for clinical research at Madigan Army Medical Center in Tacoma, Washington. This contract was issued under the authority of Federal Acquisition Regulation (FAR) Subpart...
- This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for $33,826,992.00. The contract is for HIV vaccine design research, including human leukocyte antigen (HLA) typing and epitope mapping. The contract has no set-aside designation. MGH is a non-profit, 999-bed teaching hospital affiliated with Harvard Medical School that conducts extensive biomedical...
- This federal contract award to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) is for $92,445,087.00 to conduct "COVID-19" research and development, including completing clinical studies and trials to prepare for the evaluation of medical countermeasures. The contract, awarded by the Joint Program Executive Office for Chemical, Biological, Defensive (JPEO-CBD), is an Other Transaction Agreement with no set-aside designation and a completion date...
- This is a cost-plus-fixed-fee delivery order awarded to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), a non-profit organization, by the U.S. Navy Bureau of Medicine and Surgery. The $4,260,169.62 award provides "Advance Research Expertise for Naval Medical Research Unit-San Antonio (NAMRU-SA)" under the Navy Medicine R&D Support Omnibus III contract vehicle. This award does not have a set-aside designation. HJF has a strong track record of...